PUBLICATION

MYLIP attenuates hypoxia tolerance by inducing K27-linked polyubiquitination and subsequent proteasomal degradation of HIF-α

Authors
Li, J., Li, Z., Li, X., Li, Z., Song, Y., Yuan, L., Wang, Y., Yan, R., Lai, F., Wang, J., Xiao, W.
ID
ZDB-PUB-250522-10
Date
2025
Source
Communications biology   8: 774774 (Journal)
Registered Authors
Li, Xiong, Wang, Jing, Xiao, Wuhan
Keywords
none
MeSH Terms
  • Proteolysis
  • Proteasome Endopeptidase Complex*/metabolism
  • Mice
  • Humans
  • Zebrafish
  • Basic Helix-Loop-Helix Proteins*/genetics
  • Basic Helix-Loop-Helix Proteins*/metabolism
  • Ubiquitination*
  • Hypoxia*/metabolism
  • Signal Transduction
  • Hypoxia-Inducible Factor 1, alpha Subunit*/genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism
  • HEK293 Cells
  • Animals
  • Lysine/metabolism
  • Ubiquitin-Protein Ligases*/genetics
  • Ubiquitin-Protein Ligases*/metabolism
PubMed
40399570 Full text @ Commun Biol
Abstract
Hypoxia tolerance is mainly controlled by the hypoxia signaling pathway and HIF-1α/2α serve as master regulators in this pathway. Here we identify MYLIP, an E3 ubiquitin ligase thought to specifically target lipoprotein receptors, as a downstream target of HIF-2α and a negative regulator of both HIF-1α and HIF-2α. MYLIP interacts with HIF-1α/2α and catalyzes K27-linked polyubiquitination at lysine 118/442 (HIF-1α) or lysine 117 (HIF-2α). This modification induces proteasomal degradation of HIF-1α, resulting in inhibition of hypoxia signaling. Furthermore, Mylip-deficient bluntsnout bream, zebrafish and mice are more tolerant to hypoxia. These findings reveal a role for MYLIP in regulating hypoxia signaling and identify a target for the development of fish strains with high hypoxia tolerance for the benefit of the aquaculture industry.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping